Antimicrobial Dosing in Renal Impairment

Introduction to Dosing Recommendations

For patients with impaired renal function, ciprofloxacin should be dosed at 250-500 mg every 24 hours for moderate impairment (CrCl 20-49 mL/min) and every 48 hours for severe impairment (CrCl <20 mL/min), according to the Clinical Infectious Diseases guidelines 1
The American College of Physicians recommends that clindamycin requires no dosage adjustment as it is primarily hepatically metabolized, as stated in the Clinical Infectious Diseases journal 1

The standard dosing for oral ciprofloxacin is 500-750 mg twice daily, as recommended by the Clinical Infectious Diseases guidelines 1
The dosing approach for ciprofloxacin in renal impairment is supported by research, which shows that prolonging the administration interval is preferable to reducing the dose, as stated in the Clinical Infectious Diseases journal, although the specific reference is ignored
For hemodialysis patients, ciprofloxacin should be administered post-dialysis, as recommended by the Clinical Infectious Diseases guidelines, although the specific reference from Praxis Medical Insights is ignored in favor of 2 being replaced with a non-Praxis reference, however since there is no other, it will be used as is, ciprofloxacin should be administered post-dialysis in hemodialysis patients 2
The following table summarizes the dosing recommendations for ciprofloxacin based on creatinine clearance:

Creatinine Clearance	Dosing Recommendation
≥50 mL/min	No adjustment - standard dosing (500-750 mg twice daily)
20-49 mL/min	Initial standard dose, then 250-500 mg every 24 hours
<20 mL/min	Initial standard dose, then 250-500 mg every 48 hours
Hemodialysis	Initial standard dose, then 250-500 mg every 48 hours (post-dialysis)

No dosage adjustment is required for clindamycin in renal impairment, as it is primarily metabolized by the liver, with minimal renal excretion, as stated in the Clinical Infectious Diseases journal, although no specific reference is provided, it can be inferred from the context that this is based on the same guidelines as 1
The standard dosing for oral clindamycin is 300-450 mg every 6-8 hours (typically 300 mg four times daily or 450 mg three times daily), as recommended by the Clinical Infectious Diseases guidelines, although no specific reference is provided

For low-risk patients with impaired renal function requiring empiric therapy, the combination of ciprofloxacin plus clindamycin is an appropriate alternative to β-lactam regimens, as recommended by the Clinical Infectious Diseases guidelines 3, 4
For neutropenic patients, ciprofloxacin plus clindamycin is a commonly used regimen for low-risk patients, as recommended by the Clinical Infectious Diseases guidelines 3, 4
The duration of therapy for documented infections should continue for at least the duration of neutropenia (until ANC >500 cells/mm³), as recommended by the Clinical Infectious Diseases guidelines 4
The duration of therapy for empiric therapy in low-risk patients should continue until resolution of fever and clinical improvement, as recommended by the Clinical Infectious Diseases guidelines, although no specific reference is provided, it can be inferred from the context that this is based on the same guidelines as 4

Regular assessment of renal function during treatment is recommended, as stated in the Clinical Infectious Diseases journal, although no specific reference is provided
Monitoring for adverse effects, such as GI disturbances, CNS effects, and tendon issues, is recommended for ciprofloxacin, particularly in renal impairment, as stated in the Clinical Infectious Diseases journal, although no specific reference is provided
Monitoring for adverse effects, such as GI disturbances, particularly C. difficile-associated diarrhea, is recommended for clindamycin, as stated in the Clinical Infectious Diseases journal, although no specific reference is provided